FBIO Fortress Biotech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: FBIO

Price (delayed)

$2.78

Market cap

$92.35M

P/E Ratio

0.72

Dividend/share

N/A

EPS

$3.84

Enterprise value

-$111.08M

?
Relative Growth: Rel. Growth: 78
Relative Strength: Rel. Strength: 44
Relative Valuation: Rel. Valuation: 92
Relative Profitability: Rel. Profitability: 90

Fortress Biotech, Inc. ("Fortress") is an innovative biopharmaceutical company that was ranked in Deloitte's 2019 and 2020 Technology Fast 500™, annual rankings of the fastest- growing North American companies in ...

Highlights
FBIO's quick ratio has soared by 81% YoY and by 23% QoQ
The debt has decreased by 28% YoY and by 20% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.fortressbiotech.com
Peers: VCYT ALKS

Key stats

What are the main financial stats of FBIO

FBIO stock price

How has the Fortress Biotech stock price performed over time
Intraday
6.51%
1 week
-1.07%
1 month
16.81%
1 year
50.27%
YTD
-24.04%
QTD
-0.36%

Financial performance

How have Fortress Biotech's revenue and profit performed over time
Revenue
$66.16M
Gross profit
$43.81M
Operating income
-$55.81M
Net income
$127.77M
Gross margin
66.2%
Net margin
193.1%
FBIO's operating margin is up by 49% year-on-year and by 24% since the previous quarter
FBIO's operating income is up by 42% YoY and by 21% from the previous quarter
The gross profit has increased by 15% year-on-year and by 3.5% since the previous quarter
FBIO's revenue is up by 14% year-on-year and by 4.6% since the previous quarter

Price vs fundamentals

How does FBIO's price correlate with its fundamentals

Growth

What is Fortress Biotech's growth rate over time

Valuation

What is Fortress Biotech stock price valuation
P/E
0.72
P/B
0.55
P/S
1.33
EV/EBIT
-0.78
EV/EBITDA
-0.74
EV/Sales
-1.68
The P/B is 74% less than the 5-year quarterly average of 2.0 and 65% less than the last 4 quarters average of 1.5
FBIO's revenue is up by 14% year-on-year and by 4.6% since the previous quarter
The P/S is 11% below the 5-year quarterly average of 1.4 and 11% below the last 4 quarters average of 1.4

Efficiency

How efficient is Fortress Biotech business performance
The company's return on equity has surged by 163% YoY

Dividends

What is FBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FBIO.

Financial health

How did Fortress Biotech financials performed over time
The total assets is 131% more than the total liabilities
The total assets has soared by 100% YoY and by 92% from the previous quarter
FBIO's quick ratio has soared by 81% YoY and by 23% QoQ
The debt is 67% lower than the equity
The debt to equity has dropped by 90% year-on-year and by 76% since the previous quarter
The debt has decreased by 28% YoY and by 20% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.